Skip to main content
Advanced Search
Search Terms
Content Type

Exact Matches
Tag Searches
Date Options
Updated after
Updated before
Created after
Created before

Search Results

4 total results found

Dexedrine Spansule

Drug Library

(dextroamphetamine sulfate) Dexedrine Spansule (dextroamphetamine sulfate); CII Full Prescribing Information DailyMed Drug Information Summary Dexedrine Spansule is a sustained-release dextroamphetamine capsule approved for narcolepsy and for ADHD in patients ...

Class
Amphetamine
Moiety
Dextroamphetamine
Stimulant
Yes
Duration
Long-Acting
Schedule
CII
Form
Capsule
No-Swallow Option
None
Min Age
6
Max Age
16
Indication
ADHD
Indication
Narcolepsy
ADHD Use
FDA-Approved
Boxed Warning
Abuse and Addiction
Taper
Not Required
Availability
Brand and Generic

ProCentra

Drug Library

(dextroamphetamine sulfate) ProCentra (dextroamphetamine sulfate); CII Full Prescribing Information DailyMed Drug Information Summary ProCentra is an immediate-release, short-acting oral solution of single-entity dextroamphetamine sulfate, approved for ADHD fr...

Class
Amphetamine
Moiety
Dextroamphetamine
Stimulant
Yes
Duration
Short-Acting
Schedule
CII
Form
Oral Solution
No-Swallow Option
Liquid
Min Age
3
Max Age
16
Indication
ADHD
Indication
Narcolepsy
ADHD Use
FDA-Approved
Boxed Warning
Abuse and Addiction
Taper
Not Required
Availability
Brand and Generic

Xelstrym

Drug Library

(dextroamphetamine) Xelstrym (dextroamphetamine); CII Full Prescribing Information DailyMed Drug Information Summary Xelstrym is a dextroamphetamine transdermal system, the only amphetamine patch on the U.S. market, approved for ADHD from age 6 and worn up to ...

Class
Amphetamine
Moiety
Dextroamphetamine
Stimulant
Yes
Duration
Long-Acting
Schedule
CII
Form
Transdermal Patch
No-Swallow Option
Patch
Min Age
6
Indication
ADHD
ADHD Use
FDA-Approved
Boxed Warning
Abuse and Addiction
Taper
Not Required
Availability
Brand Only

Zenzedi

Drug Library

(dextroamphetamine sulfate) Zenzedi (dextroamphetamine sulfate); CII Full Prescribing Information DailyMed Drug Information Summary Zenzedi is an immediate-release, short-acting dextroamphetamine tablet approved for narcolepsy and for ADHD in patients aged 3 t...

Class
Amphetamine
Moiety
Dextroamphetamine
Stimulant
Yes
Duration
Short-Acting
Schedule
CII
Form
Tablet
No-Swallow Option
None
Min Age
3
Max Age
16
Indication
ADHD
Indication
Narcolepsy
ADHD Use
FDA-Approved
Boxed Warning
Abuse and Addiction
Taper
Not Required
Availability
Brand and Generic